Tycel Phillips, M.D., Shares Research Findings at the 2024 ASCO Annual Meeting
City of Hope's Tycel Phillips, M.D., discusses the promising results from a Phase I/II study on glofitamab for treating relapsed/refractory mantle cell lymphoma. Dr. Phillips presented findings at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
#lymphoma #lymphomaresearch #asco24
Want to learn more about City of Hope’s impact on cancer?
Subscribe to the City of Hope YouTube Channel: https://www.youtube.com/channel/cityo...
Visit our Website: https://www.cityofhope.org/
Call us at: 626-256-HOPE (4673)
Stay connected with us on social media:
► Facebook: / cityofhope
► X: / cityofhope
► Instagram: / cityofhope
► LinkedIn: / city-of-hope
